NASDAQ$XWEL
XpresSpa Group Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
XWELL's third quarter performance in 2024 was marked by growth and productivity initiatives.
XWELL, Inc. reported a revenue of $8.4 million for the third quarter of 2024, compared to $7.5 million for the 2023 third quarter. The operating loss was approximately $4.8 million, compared with an operating loss of approximately $12.1 million for the 2023 third quarter. Net loss attributable to XWELL was approximately $4.8 million, compared to approximately $11.5 million for the 2023 third quarter.
- Total revenue for the third quarter ended September 30, 2024, was $8.4 million, compared to $7.5 million for the 2023 third quarter.
- Revenue for the 2024 third quarter primarily consisted of approximately $4.9 million from XpresSpa locations and Treat locations and approximately $3.1 million from XpresTest, which includes XWELL’s bio-surveillance partnership and its HyperPointe business.
- The operating loss was approximately $4.8 million, compared with an operating loss of approximately $12.1 million for the 2023 third quarter.
- As of September 30, 2024, the Company had approximately $4.4 million of cash and cash equivalents and approximately $11.7 million in marketable securities.
Headline financials
Revenue & EPS history
XpresSpa · Revenue · Quarterly
$8.42M
Revenue by segment
XpresSpa · $6.64M total across 3 segments · Q1 2026
- XpresSpa$4.2M—63.2%
- XpresTest$1.92M—28.9%
- Naples Wax$524K—7.9%
Forward guidance
XWELL believes it's well-positioned for a strong 2025 and remains confident that its consistent strategy execution will benefit its customers, partners, employees, and shareholders.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2024
+1.1%
Avg return
Earnings day
-2.3%
Avg return
5 days after
-4.5%
Avg return
30 days after
43%
16 / 37 earnings
Positive
+24.4%
Q4 2019
Best reaction
-11.1%
Q4 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | — | — | — | |
| Q3 2025 | +0.0% | -8.4% | -9.6% | |
| Q2 2025 | -5.8% | -8.3% | -8.3% | |
| Q1 2025 | +1.2% | +12.8% | +9.3% | |
| Q4 2024 | +0.0% | +0.0% | +15.4% | |
| Q3 2024 | -1.2% | -10.6% | -24.1% | |
| Q2 2024 | +3.7% | +0.5% | -14.8% | |
| Q1 2024 | +3.4% | -8.4% | +41.6% | |
| Q4 2023 | +0.0% | +0.7% | +32.1% | |
| Q3 2023 | +6.2% | +35.4% | +31.1% | |
| Q2 2023 | -4.2% | -4.2% | -25.0% | |
| Q1 2023 | +0.0% | +4.2% | +4.2% | |
| Q4 2022 | +6.3% | -9.4% | -21.9% | |
| Q3 2022 | +0.0% | -12.3% | -10.5% | |
| Q2 2022 | -6.5% | -5.4% | +9.7% | |
| Q1 2022 | -1.1% | -18.7% | -22.0% | |
| Q4 2021 | +8.2% | +52.0% | +11.2% | |
| Q3 2021 | +11.7% | +13.1% | +25.5% | |
| Q2 2021 | -6.9% | -13.1% | -2.9% | |
| Q4 2020 | +6.4% | -3.5% | -20.8% | |
| Q3 2020 | -1.1% | -13.4% | -22.5% | |
| Q2 2020 | -6.5% | -4.2% | -42.9% | |
| Q1 2020 | -7.5% | -5.5% | +6.5% | |
| Q4 2019 | +24.4% | +26.8% | +17.1% | |
| Q3 2019 | +2.0% | -5.9% | -41.6% | |
| Q2 2019 | +0.0% | +21.2% | +31.9% | |
| Q1 2019 | +7.8% | -9.0% | -40.0% | |
| Q4 2018 | +0.3% | -12.0% | -22.7% | |
| Q3 2018 | +0.0% | +0.0% | +11.1% | |
| Q2 2018 | +0.0% | -25.0% | -20.0% | |
| Q1 2018 | -4.8% | -31.7% | -20.6% | |
| Q4 2017 | -11.1% | -24.7% | -17.3% | |
| Q3 2017 | -0.8% | -4.0% | -6.5% | |
| Q2 2017 | +11.5% | +4.4% | +9.7% | |
| Q1 2017 | +4.9% | +1.9% | +5.6% | |
| Q4 2016 | +0.9% | -9.7% | -20.8% | |
| Q3 2016 | +0.8% | -8.0% | -15.6% | |
| Q2 2016 | -1.9% | -1.0% | +1.9% | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2012 | — | — | — | |
| Q1 2012 | — | — | — | |
| Q4 2011 | — | — | — | |
| Q3 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro